EU ingredient rules · 1 min read

Liquidambar Styraciflua Balsam Extract in cosmetics: EU rules

Quick answer: Liquidambar Styraciflua Balsam Extract is a restricted cosmetic ingredient in the EU: Annex III (entry 181) allows it only within set limits, at up to 0.6% in the ready-to-use product. CosIng lists its functions as perfuming.

Key facts

Liquidambar Styraciflua Balsam Extract at a glance
INCI nameLIQUIDAMBAR STYRACIFLUA BALSAM EXTRACT
CAS number94891-28-8 / 8046-19-3
EC number305-628-1 / 232-458-4
EU statusRestricted (Annex III, entry 181)
Functions (CosIng)Perfuming

CosIng description: "Styrax; Storax; Sweet Gum". Liquidambar Styraciflua Balsam Extract is an extract of the gum exudate obtained from the trunk of the American Styrax, Liquidambar styraciflua L., Hamamelidaceae

What it does in a product

  • Perfuming: Used to add scent, and listed in CosIng under a perfuming name.

Annex III: restricted substances, entry 181

Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.

The entry is listed as Liquidambar styraciflua oil and extract (styrax)

Maximum concentration in the ready-to-use product: 0.6%

Most recent legal act listed by CosIng for this entry: Regulation (EC) 2013/344.

Scientific Committee on Consumer Safety (SCCS) opinions:

Why it matters for shelf life

The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for LIQUIDAMBAR STYRACIFLUA BALSAM EXTRACT and Annex III/181, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.